G Mark Foletta
Affiliations
- Director at Dexcom Inc (DXCM), 2025-06-18
- Director at Amn Healthcare Services Inc (AMN), 2025-05-06
- Director at Enanta Pharmaceuticals Inc (ENTA), 2025-03-14
- Evp & Chief Financial Officer at Tocagen Inc (TOCA), 2019-10-05
- Director at Regulus Therapeutics Inc. (RGLS), 2017-12-07
- Interim Cfo at Biocept Inc (BIOC), 2015-09-02
- Director at Ambit Biosciences Corp (AMBI), 2014-11-12
- Svp, Chief Financial Officer at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10
- Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AMN | $56.90 | 500 | $28,450.00 | 8,573 | 2024-02-29 | Filing |
| TOCA | $4.30 | 5,000 | $21,475.00 | 15,042 | 2019-05-28 | Filing |
| TOCA | $10.00 | 5,000 | $50,000.00 | 5,000 | 2017-04-19 | Filing |
| RGLS | $7.64 | 10,000 | $76,405.00 | 10,000 | 2015-08-13 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| DXCM | $83.13 | 2,750 | $228,604.75 | 56,621 | 2025-06-16 | Filing |
| DXCM | $117.25 | 299 | $35,056.40 | 56,398 | 2024-06-18 | Filing |
| DXCM | $116.75 | 3,007 | $351,065.15 | 56,697 | 2024-06-18 | Filing |
| DXCM | $117.77 | 475 | $55,941.56 | 59,704 | 2024-06-17 | Filing |
| DXCM | $117.16 | 2,212 | $259,159.47 | 60,179 | 2024-06-17 | Filing |